Literature DB >> 12773720

Estimating the health consequences of replacing cigarettes with nicotine inhalers.

W Sumner1.   

Abstract

BACKGROUND: A fast acting, clean nicotine delivery system might substantially displace cigarettes. Public health consequences would depend on the subsequent prevalence of nicotine use, hazards of delivery systems, and intrinsic hazards of nicotine.
METHODS: A spreadsheet program, DEMANDS, estimates differences in expected mortality, adjusted for nicotine delivery system features and prevalence of nicotine use, by extending the data and methods of the SAMMEC 3 software from the US Centers for Disease Control and Prevention. The user estimates disease risks attributable to nicotine, other smoke components, and risk factors that coexist with smoking. The public health consequences of a widely used clean nicotine inhaler replacing cigarettes were compared to historical observations and public health goals, using four different risk attribution scenarios and nicotine use prevalence from 0-100%. MAIN OUTCOME MEASURES: Changes in years of potential life before age 85 (YPL85).
RESULTS: If nicotine accounts for less than a third of smokers' excess risk of SAMMEC diseases, as it most likely does, then even with very widespread use of clean nicotine DEMANDS predicts public health gains, relative to current tobacco use. Public health benefits accruing from a widely used clean nicotine inhaler probably equal or exceed the benefits of achieving Healthy People 2010 goals.
CONCLUSIONS: Clean nicotine inhalers might improve public health as much as any feasible tobacco control effort. Although the relevant risk estimates are somewhat uncertain, partial nicotine deregulation deserves consideration as part of a broad tobacco control policy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773720      PMCID: PMC1747720          DOI: 10.1136/tc.12.2.124

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  58 in total

1.  Smoking-attributable mortality and years of potential life lost--United States, 1984.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-05-23       Impact factor: 17.586

Review 2.  Psychosocial and pharmacologic explanations of nicotine's "gateway drug" function.

Authors:  G B Lindsay; J Rainey
Journal:  J Sch Health       Date:  1997-04       Impact factor: 2.118

Review 3.  Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.

Authors:  N L Benowitz; S G Gourlay
Journal:  J Am Coll Cardiol       Date:  1997-06       Impact factor: 24.094

4.  Nicotine nasal spray and vapor inhaler: abuse liability assessment.

Authors:  K J Schuh; L M Schuh; J E Henningfield; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1997-04       Impact factor: 4.530

5.  Structural and functional changes of rat exocrine pancreas exposed to nicotine.

Authors:  P Chowdhury; R Doi; A Tangoku; P L Rayford
Journal:  Int J Pancreatol       Date:  1995-12

Review 6.  The changing cigarette, 1950-1995.

Authors:  D Hoffmann; I Hoffmann
Journal:  J Toxicol Environ Health       Date:  1997-03

7.  Self-poisoning among adults using multiple transdermal nicotine patches.

Authors:  A Woolf; K Burkhart; T Caraccio; T Litovitz
Journal:  J Toxicol Clin Toxicol       Date:  1996

8.  Effect of nicotine on lipoprotein metabolism in rats.

Authors:  L Ashakumary; P L Vijayammal
Journal:  Lipids       Date:  1997-03       Impact factor: 1.880

9.  Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance.

Authors:  B Eliasson; M R Taskinen; U Smith
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Long-term effects of inhaled nicotine.

Authors:  H L Waldum; O G Nilsen; T Nilsen; H Rørvik; V Syversen; A K Sanvik; O A Haugen; S H Torp; E Brenna
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

View more
  6 in total

1.  Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?

Authors:  S Lewis; D Arnott; C Godfrey; J Britton
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

Review 2.  Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.

Authors:  Lion Shahab; Leonie S Brose; Robert West
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

3.  Permissive nicotine regulation as a complement to traditional tobacco control.

Authors:  Walton Sumner
Journal:  BMC Public Health       Date:  2005-02-24       Impact factor: 3.295

Review 4.  Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.

Authors:  Peter N Lee; David Abrams; Annette Bachand; Gizelle Baker; Ryan Black; Oscar Camacho; Geoffrey Curtin; Smilja Djurdjevic; Andrew Hill; David Mendez; Raheema S Muhammad-Kah; Jose Luis Murillo; Raymond Niaura; Yezdi B Pithawalla; Bill Poland; Sandra Sulsky; Lai Wei; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

5.  Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products.

Authors:  Dorothy K Hatsukami
Journal:  Tob Control       Date:  2013-05       Impact factor: 7.552

6.  Introducing oral tobacco for tobacco harm reduction: what are the main obstacles?

Authors:  Yves Martinet; Abraham Bohadana; Karl Fagerström
Journal:  Harm Reduct J       Date:  2007-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.